GLP-1 obesity drugs can lead to substantial weight loss, but an important question is what the body is actually losing. New research presented at the European Congress on Obesity (ECO2026) suggests that 80-85% of weight lost during treatment [...]
GLP-1 obesity drugs can lead to substantial weight loss, but an important question is what the body is actually losing.
New research presented at the European Congress on Obesity (ECO2026) suggests that 80-85% of weight lost during treatment [...]
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
GLP-1 obesity drugs can lead to substantial weight loss, but an important question is what the body is actually losing. New research presented at the European Congress on Obesity (ECO2026) suggests that 80-85% of weight lost during treatment [...]
Open the app view to save this story, compare related coverage, and continue from the same source.